Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 2, 2013, Pages 156-167

  Zanotto Filho, Alfeu ^a   Coradini, Karine ^a   Braganhol, Elizandra ^b   Schröder, Rafael ^a   De Oliveira, Cláudia Melo ^a   Simões Pires, André ^a   Battastini, Ana Maria Oliveira ^a   Pohlmann, Adriana Raffin ^a   Guterres, Sílvia Stanisçuaski ^a   Forcelini, Cassiano Mateus ^c   Beck, Ruy Carlos Ruver ^a   Moreira, José Cláudio Fonseca ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c UNIVERSITY OF PASSO FUNDO   (Brazil)

Author keywords

Curcumin; Drug delivery; Glioma; In vivo; Lipid core nanocapsules

Indexed keywords

CURCUMIN; LIPID CORE NANOCAPSULE; NANOCAPSULE; UNCLASSIFIED DRUG; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; G2 PHASE CELL CYCLE CHECKPOINT; GLIOMA; HISTOPATHOLOGY; M PHASE CELL CYCLE CHECKPOINT; NONHUMAN; PARTICLE SIZE; RAT; TUMOR GROWTH; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; DRUG EFFECTS; MALE; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; AUTOPHAGY; CELL LINE, TUMOR; CURCUMIN; G2 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; LIPIDS; MALE; NANOCAPSULES; PARTICLE SIZE; RATS; RATS, WISTAR;

EID: 84873722541     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.10.019     Document Type: Article

References (52)

1. H. Ohgaki, and P. Kleihues Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendrial gliomas J. Neuropathol. Exp. Neurol. 64 2005 479 489
2. D. Soni, J.A. King, A.H. Kaye, and C.M. Hovens Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge J. Clin. Neurosci. 12 2005 1 5
3. R. Roesler, A.T. Brunetto, A.L. Abujamra, C.B. de Farias, A.L. Brunetto, and G. Schwartsmann Current and emerging molecular targets in glioma Expert Rev. Anticancer Ther. 10 2010 1735 1751
4. C. Brennan, H. Momota, D. Hambardzumyan, T. Ozawa, A. Tandon, A. Pedraza, and E. Holland Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations PLoS ONE 4 2009 e7752
5. P. Anand, H.B. Nair, B. Sung, A.B. Kunnumakkara, V.R. Yadav, R.R. Tekmal, and B.B. Aggarwal Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo Biochem. Pharmacol. 79 2010 330 338
6. A. Zanotto-Filho, E. Braganhol, R. Schröder, L.H. de Souza, R.J. Dalmolin, M.A. Pasquali, D.P. Gelain, A.M. Battastini, and J.C. Moreira NFκB inhibitors induce cell death in glioblastomas Biochem. Pharmacol. 81 2011 412 424
7. A. Zanotto-Filho, E. Braganhol, M.I. Edelweiss, G.A. Behr, R. Zanin, R. Schröder, A. Simões-Pires, A.M. Battastini, and J.C. Moreira The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma J. Nutr. Biochem. 23 2012 591 601
8. W. Zhuang, L. Long, B. Zheng, W. Ji, N. Yang, Q. Zhang, and Z. Liang Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy Cancer Sci. 103 2012 684 690
9. J. Weissenberger, M. Priester, C. Bernreuther, S. Rakel, M. Glatzel, V. Seifert, and D. Kögel Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway Clin. Cancer Res. 16 2010 5781 5795
10. C. Senft, M. Polacin, M. Priester, V. Seifert, D. Kögel, and J. Weissenberger The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas BMC Cancer 10 2010 491 499
11. T.Y. Huang, T.H. Tsai, C.W. Hsu, and Y.C. Hsu Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells J. Agric. Food Chem. 58 2010 10639 10645
12. C.C. Su, M.J. Wang, and T.L. Chiu The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma Int. J. Mol. Med. 26 2010 217 224
13. M.C. Perry, M. Demeule, A. Régina, and R. Moumdjian R, Béliveau, Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts Mol. Nutr. Food Res. 54 2010 1192 1201
14. K.M. Dhandapani, V.B. Mahesh, and D.W. Brann Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors J. Neurochem. 102 2007 522 538
15. A.S. Strimpakos, and R.A. Sharma Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials Antioxid. Redox Signal. 10 2008 511 545
16. R.E. Carroll, R.V. Benya, D.K. Turgeon, S. Vareed, M. Neuman, L. Rodriguez, M. Kakarala, P.M. Carpenter, C. McLaren, F.L. Meyskens Jr., and D.E. Brenner Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prev. Res. (Phila) 4 2011 354 364
17. M. Kanai, K. Yoshimura, M. Asada, A. Imaizumi, C. Suzuki, S. Matsumoto, T. Nishimura, Y. Mori, T. Masui, Y. Kawaguchi, K. Yanagihara, S. Yazumi, T. Chiba, S. Guha, and B.B. Aggarwal A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer Cancer Chemother. Pharmacol. 68 2011 157 164
18. M. Bayet-Robert, F. Kwiatkowski, M. Leheurteur, F. Gachon, E. Planchat, C. Abrial, M.A. Mouret-reynier, X. Durando, C. Barthomeuf, and P. Chollet Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer Cancer Biol. Ther. 9 2010 8 14
19. C.H. Hsu, and A.L. Cheng Clinical studies with curcumin Adv. Exp. Med. Biol. 595 2007 471 480
20. Y.M. Tsai, C.F. Chien, L.C. Lin, and T.H. Tsai Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration Int. J. Pharm. 416 2011 331 338
21. M. Sun, Y. Gao, C. Guo, F. Cao, Z. Song, Y. Xi, A. Yu, A. Li, and G. Zhai Enhancement of transport of curcumin to brain in mice by poly(n- butylcyanoacrylate) nanoparticle J. Nanoparticle Res. 12 2010 3111 3122
22. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
23. B. Wahlang, Y.B. Pawar, and A.K. Bansal Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model Eur. J. Pharm. Biopharm. 77 2011 275 282
24. H.H. Tonnesen, M. Másson, and T. Loftsson Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability Int. J. Pharm. 244 2002 127 135
25. V. Kakkar, S. Singh, D. Sinla, and I.P. Kaur Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol. Nutr. Food Res. 55 2011 495 503
26. C. Puglia, G. Frasca, T. Musumeci, L. Rizza, G. Puglisi, F. Bonina, and S. Chiechio Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice Eur. J. Pharm. Biopharm. 81 2012 288 293
27. K. Maiti, K. Mukherjee, A. Gantait, B.P. Saha, and P.K. Mukherjee Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats Int. J. Pharm. 330 2007 155 163
28. V.R. Yadav, S. Prasad, R. Kannappan, J. Ravindran, M.M. Chaturvedi, L. Vaahtera, J. Parkkinen, and B.B. Aggarwal Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake Biochem. Pharmacol. 80 2010 1021 1032
29. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and R.M.N.V. Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 37 2009 223 230
30. C. Mohanty, and S.K. Sahoo The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation Biomaterials 31 2010 6597 6611
31. E. Garcia-Garcia, K. Andrieux, S. Gil, and P. Couvreur Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int. J. Pharm. 298 2005 274 292
32. A. Bernardi, E. Braganhol, E. Jäger, F. Figueiró, M.I. Edelweiss, A.R. Pohlmann, S.S. Guterres, and A.M.O. Battastini Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model Cancer Lett. 281 2009 53 63
33. M.C. Fontana, K. Coradini, S.S. Guterres, A.R. Pohlmann, and R.C.R. Beck Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system J. Biomed. Nanotechnol. 5 2009 254 263
34. R.L. Frozza, A. Bernardi, K. Paese, J.B. Hoppe, T. Silva, A.M.O. Battastini, A.R. Pohlmann, S.S. Guterres, and C. Salbego Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats J. Biomed. Nanotechnol. 6 2010 694 703
35. A.F. Ourique, S. Azoubel, C.V. Ferreira, C.B. Silva, M.C.L. Marchiori, A.R. Pohlmann, S.S. Guterres, and R.C.R. Beck Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: development and in vitro antitumor activity on human myeloid leukaemia Cells J. Biomed. Nanotechnol. 6 2010 214 223
36. C.G. Venturini, E. Jäger, C.P. Oliveira, A. Bernardi, A.M.O. Battastini, S.S. Guterres, and A.R. Pohlmann Formulation of lipid core nanocapsules Colloid Surf. A 375 2011 200 208
37. E. Jäger, C.G. Venturini, F.S. Polleto, L.M. Colomé, J.P.U. Pohlmann, A. Bernardi, A.M.O. Battastini, S.S. Guterres, and A.R. Pohlmann Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area J. Biomed. Nanotechnol. 5 2009 130 140
38. European Union L 275 OJEU 54 2011 38 40
39. V. Filipe, A. Hawe, and W. Jiskoot Critical evaluation of nanoparticle Tracking Analysis (NTA) by Nanosight for the measurement of nanoparticles and protein aggregates Pharm. Res. 27 2010 796 810
40. R.D. Boyd, S.K. Pichaimuthu, and A. Cuenat New approach to inter-technique comparisons for nanoparticle size measurements; using atomic force microscopy, nanoparticle tracking analysis and dynamic light scattering Colloid Surf. A 387 2011 35 42
41. B.K. Jadhav, K.R. Mahadik, and A.R. Paradkar Reversed phase-HPLC method for simultaneous determination of curcumin, demethoxycurcumin and bis-demethoxycurcumin Chromatographia 65 2007 483 488
42. O. Mengual, G. Meunier, I. Cayré, K. Puech, and P. Snabre TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis Talanta 50 1999 445 456
43. L.M. Luttrell, Y. Daaka, G.J. Della Rocca, and R.J. Lefkowitz G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases J. Biol. Chem. 272 1997 31648 31656
44. A. Zanotto-Filho, A. Delgado-Cañedo, R. Schröder, M. Becker, F. Klamt, and J.C. Moreira The pharmacological NFkappaB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation Cancer Lett. 288 2010 192 203
45. T. Takano, J.H.C. Lin, G. Arcuino, Q. Gao, J. Yang, and M. Nedergaard Glutamate release promotes growth of malignant gliomas Nat. Med. 7 2001 1010 1015
46. I.C. Külkamp, B.D. Rabelo, S.J. Berlitz, M. Isoppo, M.D. Bianchin, S.R. Schaffazick, A.R. Pohlmann, and S.S. Guterres Nanoencapsulation improves the in vitro antioxidant activity of lipoic acid J. Biomed. Nanotechnol. 7 2011 598 607
47. M.C. Fontana, K. Coradini, A.R. Pohlmann, S.S. Guterres, and R.C.R. Beck Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release and photostability J. Nanosci. Nanotechnol. 10 2010 3091 3099
48. J. Shao, D. Zheng, Z. Jiang, H. Xu, Y. Hu, X. Li, and X. Lu Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells Acta Biochim. Biophys. Sin. 43 2011 267 274
49. P. Kundu, C. Mohanty, and S.K. Sahoo Antiglioma activity of curcumin loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy Acta Biomater. 8 2012 2670 2687
50. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20
51. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long circulating and target specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
52. M.M. Yallapu, M.C. Ebeling, N. Chauhan, M. Jaggi, and S.C. Chauhan Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes Int. J. Nanomed. 6 2011 2779 2790